FDA Qualified Health Claims for Yogurt and Type 2 Diabetes

Trending News

Changes to Civil Rights Enforcement: New Executive Order Eliminates Disparate-Impact Liability in Federal Regulations

How Are Family Offices Building Smarter Wealth? Structural Alpha (11 Examples)

DOJ Rule Restricting Sensitive Data Transfers Takes Effect

The Trump Administration’s Diversity, Equity, and Inclusion (DEI) Executive Orders: A Brief Primer

Trump Administration Announces "Reciprocal" Tariffs

What Every Multinational Company Should Know About … The Global and Reciprocal Tariffs Announcement

Blockading the Ports: U.S. Imposes 10% Global Tariff; Higher Reciprocal Tariff Rates by Country

Fifth Circuit Court of Appeals Negates Ruling on Federal Contractor Minimum Wage

New Executive Order Rescinds the $17.75 Per Hour Federal Contractor Minimum Wage

Medicare Telehealth Gets Another Temporary Lifeline – Will Congress Make it Permanent?

Food and Drug Law at Keller and Heckman

Email

202-434-4100

Bio and Articles

Find Your Next Job !

Early Career Trial Attorney - Las Vegas, Nevada (Remote)

Attorney Represented Bodily Injury Adjuster I, II or Sr

Legal Secretary / Typist

Explore More Job Openings

FDA Announces Qualified Health Claim for Yogurt and Reduced Risk of Type 2 Diabetes

by: Food and Drug Law at Keller and Heckman of Keller and Heckman LLP - The Daily Intake

Friday, March 1, 2024

Print Mail Download info_icon_img

info_icon_img

On March 1, 2024, the U.S. Food and Drug Administration (FDA) announced in a letter of enforcement discretion that it does not object to the use of certain qualified health claims regarding the consumption of yogurt and reduced risk of type 2 diabetes, provided that the qualified health claims are worded so as not to mislead consumers, and that other factors for the use of the claim are met.
A health claim characterizes the relationship between a substance and a disease or health-related condition. A qualified health claim is supported by scientific evidence, but does not meet the more rigorous “significant scientific agreement” standard required for an authorized health claim.
The letter is in response to a petition submitted on behalf of Danone North America that requested the Agency to review this qualified health claim. The petition also noted that the evidence supports the health effects of yogurt as food rather than related to any single nutrient or compound and thus is independent of fat and sugar content. FDA determined that there is some credible evidence supporting a relationship between yogurt intake and reduced risk of type 2 diabetes, but this evidence is limited.
FDA considers 2 cups (3 servings) per week of yogurt to be the minimum amount for this qualified health claim. FDA intends to consider exercising its enforcement discretion for the following qualified health claims regarding the relationship between yogurt and reduced risk of type 2 diabetes:
- “Eating yogurt regularly, at least 2 cups (3 servings) per week, may reduce the risk of type 2 diabetes. FDA has concluded that there is limited information supporting this claim.”
- “Eating yogurt regularly, at least 2 cups (3 servings) per week, may reduce the risk of type 2 diabetes according to limited scientific evidence.”

Current Public Notices

Post Your Public Notice Today!

PUBLIC NOTICE OF UCC ARTICLE 9 SALE: Revel Bikes Acquisitions Inc, Why Cycles Inc, Revel Bikes Holdco, LLC

Published: 7 May, 2025

PUBLIC NOTICE OF UCC ARTICLE 9 SALE: Veil Global Technologies, Inc

Published: 6 May, 2025

PUBLIC NOTICE OF AUCTION OF ASSETS: Rustic Crust, Inc

Published: 2 May, 2025

PUBLIC NOTICE OF UCC ARTICLE 9 SALE: CCP Mezzanine Nashville I, LLC

Published: 24 April, 2025

PUBLIC NOTICE OF 363 SALE: Elmer Buchta Trucking

Published: 31 March, 2025

PUBLIC NOTICE OF UCC ARTICLE 9 SALE: PHILLIPS AMSTERDAM II LLC

Published: 31 March, 2025

Discover more public notices

Current Legal Analysis

Chairman Atkins Outlines SEC’s New Roadmap for Crypto Reform

by: Christopher J. Bosch , Maxwell Earp-Thomas

Justices Reject “Moment of Threat” Rule in Police Shooting Case - SCOTUS Today

by: Stuart M. Gerson

Employer Compliance with Illinois E-Verify Law Still Necessary Despite DOJ Lawsuit

by: Amy L. Peck

When States Step In: PFAS Policy Innovation or Fragmentation?

by: L. Claire Hansen , Carla N. Hutton

“AI Policy Roadmap” Released by AdvaMed to Guide Regulators

by: Sheridan A. Organ , Kyle Y. Faget

More from Keller and Heckman LLP

Regulation on Preventing the Loss of Plastic Pellets to Reduce Microplastic Pollution – Draft Agreement Reached Between the Council and the Parliament

by: Ales Bartl , Alejandra Martínez Perea

Texas Launches Another Investigation into Healthy Claims in Cereals

by: Food and Drug Law at Keller and Heckman

FDA Approves Three New Natural Food Colors

by: Food and Drug Law at Keller and Heckman

FDA and HHS Announce Next Steps in “Operation Stork Speed”

by: Food and Drug Law at Keller and Heckman

FDA Announces Expanded Use of Unannounced Inspections at Foreign Manufacturing Facilities

by: Food and Drug Law at Keller and Heckman

FDA and NIH Launch Joint Nutrition Regulatory Science Program

by: Food and Drug Law at Keller and Heckman

FDA Extends Comment Period for Front-of-Package Nutrition Labeling Rule

by: Food and Drug Law at Keller and Heckman

FDA Releases 2023 CORE Annual Report

by: Food and Drug Law at Keller and Heckman

FDA to Rehire Some Staff

by: Food and Drug Law at Keller and Heckman

Proposed System to Define Ultra-Processed Foods

by: Food and Drug Law at Keller and Heckman

April 2025 Bounty Hunter Plaintiff Claims

by: Sophia B. Castillo , Mitzi Ng Clark

CPSC Advances Lithium-Ion Battery Safety Standard for E-Mobility Devices

by: Sheila A. Millar , Antonia Stamenova-Dancheva

FDA Scores Win in Wages, but Industry Eyes Fifth Circuit Remand in Flavored Vape PMTA Denial Challenge

by: Azim Chowdhury , Eric P. Gotting

Re-evaluation of Acesulfame K (E 950) as Food Additive

by: Food and Drug Law at Keller and Heckman

Draft FDA Budget Proposes Cutting Funding, Shifting Food Inspections to States

by: Food and Drug Law at Keller and Heckman

Upcoming Events

May

22

2025

Kidd Aitken & Chambers USA Q&A

May

20

2025

To Note or Not to Note

May

20

2025

Reception during the 2025 American Clean Power Conference

May

21

2025

OSHA 30/30 - May 21, 2025

Print